Evidence map›Paper›PMID 38298272›Full record

ArticleEC psychology and psychiatry2024

Evidence Based Clinical Analytics Supporting the Genetic Addiction Risk Severity (GARS) Assessment to Early Identify Probands in Preaddiction.

Kenneth Blum, Abdalla Bowirrat, Panayotis K Thanos, Colin Hanna, Jag Khalsa, David Baron, Igor Elman, Rajendra D Badgaiyan, Catherine Dennen, Eric R Braverman and 4 more

Abstract read
In one paragraph

Article in EC psychology and psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Kenneth BlumDepartment of Molecular Biology and Adelson School of Medicine, Ariel University, Ariel, Israel.
Abdalla BowirratDepartment of Molecular Biology and Adelson School of Medicine, Ariel University, Ariel, Israel.
Panayotis K ThanosBehavioral Neuropharmacology and Neuroimaging Laboratory, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, Clinical Research Institute on Addictions, University at Buffalo, Buffalo, NY, USA.
Colin HannaBehavioral Neuropharmacology and Neuroimaging Laboratory, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, Clinical Research Institute on Addictions, University at Buffalo, Buffalo, NY, USA.
Jag KhalsaUS National Institute on Drug Abuse, NIH, Medical Consequences of Drug Abuse and Infections Branch, National Institute on Drug Abuse, NIH, Bethesda, Maryland, USA.
David BaronCenter for Sports, Exercise, Global Mental Health, Western University Health Sciences, Pomona, CA, USA.
Igor ElmanCambridge Health Alliance, Harvard Medical School, Cambridge, MA, USA.
Rajendra D BadgaiyanDepartment of Psychiatry, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Catherine DennenDepartment of Family Medicine, Jefferson Health Northeast, Philadelphia, PA, USA.
Eric R BravermanCenter for Sports, Exercise, Global Mental Health, Western University Health Sciences, Pomona, CA, USA.
Paul CarneyDivision Pediatric Neurology, University of Missouri, School of Medicine, Columbia, MO, USA.
Kai-Uwe LewandrowskiDepartment of Orthopaedics, Fundación Universitaria Sanitas, Bogotá, DC, Colombia.
Alireza SharafshahCellular and Molecular Research Center, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
Mark S GoldDepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.

Funding

Prenatal Tobacco and Cannabis Exposure: A Translational StudyR33DA045640 · NIDA · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI EIDEN, RINA D, THANOS, PANAYOTIS K · 2021 to 2023
$999k
Prenatal Tobacco and Cannabis Exposure: A Translational StudyR21DA045640 · NIDA · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI EIDEN, RINA D, THANOS, PANAYOTIS K · 2018 to 2019
$434k
A Systematic Medical Approach to Reward Transformation (SMART) for Brain Health in Opioid Use DisorderR41MD012318 · NIMHD · VERSA INTEGRATED SOLUTIONS, INC. · PI BLUM, KENNETH, GONDRE-LEWIS, MARJORIE C · 2017 to 2017
$221k
Dopamine Neurotransmission in AddictionI01CX000479 · VA · VA WESTERN NEW YORK HEALTHCARE SYSTEM · PI BADGAIYAN, RAJENDRA D · 2013 to 2014
–
Dopamine neurotransmission in Gulf War Veteran's IllnessI01CX002099 · VA · SOUTH TEXAS VETERANS HEALTH CARE SYSTEM · PI BADGAIYAN, RAJENDRA D · 2021 to 2021
–
CSRD VA I01 CX000479CSRD VA I01 CX002099NIDA NIH HHS R21 DA045640NIDA NIH HHS R33 DA045640NIMHD NIH HHS R41 MD012318
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38298272
PMCPMC10825809

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.